Olympus (OTCMKTS:OCPNY) Shares Cross Below Two Hundred Day Moving Average – What’s Next?
by Doug Wharley · The Cerbat GemOlympus Co. (OTCMKTS:OCPNY – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group upgraded Olympus to a “buy” rating in a research report on Monday. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.
Read Our Latest Research Report on Olympus
Olympus Stock Performance
The stock has a 50-day moving average of $18.00 and a 200 day moving average of $18.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.99 and a quick ratio of 1.48. The stock has a market capitalization of $23.15 billion, a price-to-earnings ratio of 21.95, a price-to-earnings-growth ratio of 1.07 and a beta of 0.70.
About Olympus
Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.
In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.